RNS Number : 0140T
Legal & General UCITS ETF PLC
14 July 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
14/07/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
141969169.17 |
12.065 |
| L&G UK Equity UCITS ETF |
14/07/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10972362.67 |
9.144 |
| L&G Global Equity UCITS ETF |
14/07/2020 |
IE00BFXR5S54 |
2900000 |
USD |
33588099.87 |
11.582 |
| L&G Japan Equity UCITS ETF |
14/07/2020 |
IE00BFXR5T61 |
11185000 |
USD |
117947857.12 |
10.545 |
| L&G Europe ex UK Equity UCITS ETF |
14/07/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
102561646.90 |
10.956 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
14/07/2020 |
IE00BFXR5W90 |
5081427 |
USD |
53488471.33 |
10.526 |
| L&G Clean Water UCITS ETF |
14/07/2020 |
IE00BK5BC891 |
1500000 |
USD |
15730332.92 |
10.487 |
| L&G Artificial Intelligence UCITS ETF |
14/07/2020 |
IE00BK5BCD43 |
7596000 |
USD |
100183207.51 |
13.189 |
| L&G Healthcare Innovation UCITS ETF |
14/07/2020 |
IE00BK5BC677 |
3000000 |
USD |
38891232.59 |
12.964 |
| L&G Pharma Breakthrough UCITS ETF |
14/07/2020 |
IE00BF0H7608 |
2150000 |
USD |
26310669.45 |
12.238 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
14/07/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
94950009.39 |
10.321 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
14/07/2020 |
IE00BKLWY790 |
57800000 |
USD |
628113089.46 |
10.867 |
| L&G Battery Value-Chain UCITS ETF |
14/07/2020 |
IE00BF0M2Z96 |
12950000 |
USD |
129344161.72 |
9.988 |
| L&G Ecommerce Logistics UCITS ETF |
14/07/2020 |
IE00BF0M6N54 |
5950000 |
USD |
66003877.08 |
11.093 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
14/07/2020 |
IE00BMW3QX54 |
47430616 |
USD |
834706376.80 |
17.598 |
| L&G Cyber Security UCITS ETF |
14/07/2020 |
IE00BYPLS672 |
82161776 |
USD |
1572833284.20 |
19.143 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVFZGMNZDNGGZZ
